These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
709 related articles for article (PubMed ID: 9973048)
21. Efficacy of postoperative blood salvage following total hip arthroplasty in patients with and without deposited autologous units. Grosvenor D; Goyal V; Goodman S J Bone Joint Surg Am; 2000 Jul; 82-A(7):951-4. PubMed ID: 10901309 [TBL] [Abstract][Full Text] [Related]
22. [Limited, haemoglobin-dependent indication for autologous blood donation in total hip or knee replacement]. Willburger RE; Meiser A; Sari B; Casagranda O; Laubenthal H; Kleinert H Z Orthop Ihre Grenzgeb; 2006; 144(2):199-205. PubMed ID: 16625451 [TBL] [Abstract][Full Text] [Related]
23. Patient blood management in elective total hip- and knee-replacement surgery (part 2): a randomized controlled trial on blood salvage as transfusion alternative using a restrictive transfusion policy in patients with a preoperative hemoglobin above 13 g/dl. So-Osman C; Nelissen RG; Koopman-van Gemert AW; Kluyver E; Pöll RG; Onstenk R; Van Hilten JA; Jansen-Werkhoven TM; van den Hout WB; Brand R; Brand A Anesthesiology; 2014 Apr; 120(4):852-60. PubMed ID: 24434302 [TBL] [Abstract][Full Text] [Related]
24. Value of the autotransfusion of blood recovered from the post-operative wound in arthroplasty patients. Rojewski M; Król R; Krzykawski R; Prochacki P Ortop Traumatol Rehabil; 2009; 11(5):448-57. PubMed ID: 19920287 [TBL] [Abstract][Full Text] [Related]
25. [Evaluation of perioperative blood loss and transfusion in total knee arthroplasty]. Yamaguchi S; Ohno G; Kitamura J Masui; 2014 Sep; 63(9):1029-33. PubMed ID: 25255666 [TBL] [Abstract][Full Text] [Related]
26. Effectiveness of autologous transfusion system in primary total hip and knee arthroplasty. Schneider MM; Kendoff D; Oloughlin PF; Hessling C; Gehrke T; Citak M Technol Health Care; 2014; 22(1):123-8. PubMed ID: 24361982 [TBL] [Abstract][Full Text] [Related]
27. The incidence and risk factors for allogenic blood transfusion in total knee and hip arthroplasty. Song K; Pan P; Yao Y; Jiang T; Jiang Q J Orthop Surg Res; 2019 Aug; 14(1):273. PubMed ID: 31455380 [TBL] [Abstract][Full Text] [Related]
28. Risk factors for infection, revision, death, blood transfusion and longer hospital stay 3 months and 1 year after primary total hip or knee arthroplasty. Rhee C; Lethbridge L; Richardson G; Dunbar M Can J Surg; 2018 Jun; 61(3):165-176. PubMed ID: 29806814 [TBL] [Abstract][Full Text] [Related]
29. Allogeneic blood transfusions and postoperative infections after total hip or knee arthroplasty. Friedman R; Homering M; Holberg G; Berkowitz SD J Bone Joint Surg Am; 2014 Feb; 96(4):272-8. PubMed ID: 24553882 [TBL] [Abstract][Full Text] [Related]
30. Blood transfusion strategies for total knee arthroplasty: minimizing autologous blood wastage, risk of homologous blood transfusion, and transfusion cost. Knight JL; Sherer D; Guo J J Arthroplasty; 1998 Jan; 13(1):70-6. PubMed ID: 9493540 [TBL] [Abstract][Full Text] [Related]
31. The reduction of preoperative autologous blood donation for primary total hip or knee arthroplasty: the effect on subsequent transfusion rates. Couvret C; Tricoche S; Baud A; Dabo B; Buchet S; Palud M; Fusciardi J Anesth Analg; 2002 Apr; 94(4):815-23, table of contents. PubMed ID: 11916778 [TBL] [Abstract][Full Text] [Related]
32. Blood management in total hip replacement: an analysis of factors associated with allogenic blood transfusion. Wong S; Tang H; de Steiger R ANZ J Surg; 2015 Jun; 85(6):461-5. PubMed ID: 25781570 [TBL] [Abstract][Full Text] [Related]
33. Retransfusion of filtered shed blood in everyday orthopaedic practice. Moonen AF; Thomassen BJ; van Os JJ; Verburg AD; Pilot P Transfus Med; 2008 Dec; 18(6):355-9. PubMed ID: 19140818 [TBL] [Abstract][Full Text] [Related]
34. Transfusion needs in hip and knee arthroplasty. Kurdy NM Ann Chir Gynaecol; 1996; 85(1):86-9. PubMed ID: 8739940 [TBL] [Abstract][Full Text] [Related]
35. Analysis of transfusion predictors in shoulder arthroplasty. Millett PJ; Porramatikul M; Chen N; Zurakowski D; Warner JJ J Bone Joint Surg Am; 2006 Jun; 88(6):1223-30. PubMed ID: 16757754 [TBL] [Abstract][Full Text] [Related]
37. Blood management for patients with hemoglobin level lower than 130 g/l in total knee arthroplasty. Minoda Y; Sakawa A; Fukuoka S; Tada K; Takaoka K Arch Orthop Trauma Surg; 2004 Jun; 124(5):317-9. PubMed ID: 15060833 [TBL] [Abstract][Full Text] [Related]
38. Comparative Risk of Transfusion and Incremental Total Hospitalization Cost for Primary Unilateral, Bilateral, and Revision Total Knee Arthroplasty Procedures. Nichols CI; Vose JG J Arthroplasty; 2016 Mar; 31(3):583-9.e1. PubMed ID: 26699673 [TBL] [Abstract][Full Text] [Related]
39. Prevalence of anemia and association with outcome in joint arthroplasty - is there a difference between primary and revision cases? Schmidt-Braekling T; Sabri E; ; Kim PR; Gofton WT; Beaulé PE; Grammatopoulos G Arch Orthop Trauma Surg; 2024 May; 144(5):2337-2346. PubMed ID: 38416136 [TBL] [Abstract][Full Text] [Related]
40. Preoperative use of recombinant human erythropoietin before total joint arthroplasty. Bezwada HP; Nazarian DG; Henry DH; Booth RE J Bone Joint Surg Am; 2003 Sep; 85(9):1795-800. PubMed ID: 12954840 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]